Glaxo ’s New Research Chief Loves Big Pharma. Now He Has To Fix It

GlaxoSmithKline is turning to a new chief scientific officer, Hal Barron, to reinvigorate its drug pipeline.

Source: Forbes.com Healthcare News - July 24, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news